UK Markets open in 2 hrs 9 mins

AgeX Therapeutics, Inc. (AGE)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.8200-0.1170 (-12.49%)
At close: 04:00PM EST
0.8400 +0.02 (+2.44%)
After hours: 04:56PM EST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.0600
52-week low 30.5160
50-day moving average 30.7537
200-day moving average 31.1176

Share statistics

Avg vol (3-month) 3581.02k
Avg vol (10-day) 31.27M
Shares outstanding 537.94M
Implied shares outstanding 6N/A
Float 818.45M
% held by insiders 143.47%
% held by institutions 117.64%
Shares short (14 Dec 2021) 4412.24k
Short ratio (14 Dec 2021) 43.53
Short % of float (14 Dec 2021) 42.00%
Short % of shares outstanding (14 Dec 2021) 41.09%
Shares short (prior month 14 Nov 2021) 4408k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 215:16
Last split date 305 May 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-519.91%

Management effectiveness

Return on assets (ttm)-174.68%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.78M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-65.20%
Gross profit (ttm)1.71M
Net income avi to common (ttm)-9.3M
Diluted EPS (ttm)-0.2370
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)731k
Total cash per share (mrq)0.02
Total debt (mrq)11.41M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.22
Book value per share (mrq)-0.26

Cash flow statement

Operating cash flow (ttm)-7.83M
Levered free cash flow (ttm)-4.85M